| Michael T Semotuk, MD | |
|
750 E 34th St, Hibbing, MN 55746-2341 | |
| (218) 262-4881 | |
| (218) 362-6699 |
| Full Name | Michael T Semotuk |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 27 Years |
| Location | 750 E 34th St, Hibbing, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245218056 | NPI | - | NPPES |
| 34387800 | Medicaid | WI | |
| 186318500 | Medicaid | MN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grand Itasca Clinic And Hospital | Grand rapids, MN | Hospital |
| Community Memorial Hospital | Cloquet, MN | Hospital |
| University Medical Center-mesabi/ Mesaba Clinics | Hibbing, MN | Hospital |
| St Lukes Hospital | Duluth, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiologists Associated In Duluth Ltd | 4284547209 | 42 |
News Archive
As President Barack Obama prepares to release his budget proposal Tuesday, he is expected to reverse course on efforts to curb spending on Social Security. House Republicans, meanwhile, plan to release a proposal that would make sweeping changes to antipoverty programs, including Medicaid.
CellAura, the leading producer of fluorescence reagents for drug discovery and life sciences research, today announced a development partnership with Cisbio Bioassays. Under the terms of the agreement, CellAura will provide pharmacologically validated reagents to Cisbio Bioassays that will be applied to Cisbio Bioassays' Tag-lite™ range of non-radioactive assays for cellular studies.
YORKSHIRE Cancer Research will invest £5 million in research that will have a direct impact on cancer patients in Yorkshire, it has been announced today.
Boston Scientific Corporation has completed patient enrollment in the ASTI post-market clinical follow-up study designed to evaluate its Adapt Monorail Carotid Stent System in combination with its FilterWire EZ Embolic Protection System for treatment of carotid artery disease in patients at high risk for carotid surgery.
The U.S. Food and Drug Administration today approved the Imugen Babesia microti Arrayed Fluorescent Immunoassay, for the detection of antibodies to Babesia microti (B. microti) in human plasma samples, and the Imugen Babesia microti Nucleic Acid Test (NAT), for the detection of B. microti DNA in human whole blood samples.
› Verified 3 days ago
| Entity Name | Radiologists Associated In Duluth Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598722688 PECOS PAC ID: 4284547209 Enrollment ID: O20031106000469 |
News Archive
As President Barack Obama prepares to release his budget proposal Tuesday, he is expected to reverse course on efforts to curb spending on Social Security. House Republicans, meanwhile, plan to release a proposal that would make sweeping changes to antipoverty programs, including Medicaid.
CellAura, the leading producer of fluorescence reagents for drug discovery and life sciences research, today announced a development partnership with Cisbio Bioassays. Under the terms of the agreement, CellAura will provide pharmacologically validated reagents to Cisbio Bioassays that will be applied to Cisbio Bioassays' Tag-lite™ range of non-radioactive assays for cellular studies.
YORKSHIRE Cancer Research will invest £5 million in research that will have a direct impact on cancer patients in Yorkshire, it has been announced today.
Boston Scientific Corporation has completed patient enrollment in the ASTI post-market clinical follow-up study designed to evaluate its Adapt Monorail Carotid Stent System in combination with its FilterWire EZ Embolic Protection System for treatment of carotid artery disease in patients at high risk for carotid surgery.
The U.S. Food and Drug Administration today approved the Imugen Babesia microti Arrayed Fluorescent Immunoassay, for the detection of antibodies to Babesia microti (B. microti) in human plasma samples, and the Imugen Babesia microti Nucleic Acid Test (NAT), for the detection of B. microti DNA in human whole blood samples.
› Verified 3 days ago
| Entity Name | Community Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003869082 PECOS PAC ID: 0042129991 Enrollment ID: O20040202001203 |
News Archive
As President Barack Obama prepares to release his budget proposal Tuesday, he is expected to reverse course on efforts to curb spending on Social Security. House Republicans, meanwhile, plan to release a proposal that would make sweeping changes to antipoverty programs, including Medicaid.
CellAura, the leading producer of fluorescence reagents for drug discovery and life sciences research, today announced a development partnership with Cisbio Bioassays. Under the terms of the agreement, CellAura will provide pharmacologically validated reagents to Cisbio Bioassays that will be applied to Cisbio Bioassays' Tag-lite™ range of non-radioactive assays for cellular studies.
YORKSHIRE Cancer Research will invest £5 million in research that will have a direct impact on cancer patients in Yorkshire, it has been announced today.
Boston Scientific Corporation has completed patient enrollment in the ASTI post-market clinical follow-up study designed to evaluate its Adapt Monorail Carotid Stent System in combination with its FilterWire EZ Embolic Protection System for treatment of carotid artery disease in patients at high risk for carotid surgery.
The U.S. Food and Drug Administration today approved the Imugen Babesia microti Arrayed Fluorescent Immunoassay, for the detection of antibodies to Babesia microti (B. microti) in human plasma samples, and the Imugen Babesia microti Nucleic Acid Test (NAT), for the detection of B. microti DNA in human whole blood samples.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael T Semotuk, MD 23 W Central Entrance # 160, Duluth, MN 55811-3433 Ph: (218) 722-3700 | Michael T Semotuk, MD 750 E 34th St, Hibbing, MN 55746-2341 Ph: (218) 262-4881 |
News Archive
As President Barack Obama prepares to release his budget proposal Tuesday, he is expected to reverse course on efforts to curb spending on Social Security. House Republicans, meanwhile, plan to release a proposal that would make sweeping changes to antipoverty programs, including Medicaid.
CellAura, the leading producer of fluorescence reagents for drug discovery and life sciences research, today announced a development partnership with Cisbio Bioassays. Under the terms of the agreement, CellAura will provide pharmacologically validated reagents to Cisbio Bioassays that will be applied to Cisbio Bioassays' Tag-lite™ range of non-radioactive assays for cellular studies.
YORKSHIRE Cancer Research will invest £5 million in research that will have a direct impact on cancer patients in Yorkshire, it has been announced today.
Boston Scientific Corporation has completed patient enrollment in the ASTI post-market clinical follow-up study designed to evaluate its Adapt Monorail Carotid Stent System in combination with its FilterWire EZ Embolic Protection System for treatment of carotid artery disease in patients at high risk for carotid surgery.
The U.S. Food and Drug Administration today approved the Imugen Babesia microti Arrayed Fluorescent Immunoassay, for the detection of antibodies to Babesia microti (B. microti) in human plasma samples, and the Imugen Babesia microti Nucleic Acid Test (NAT), for the detection of B. microti DNA in human whole blood samples.
› Verified 3 days ago
Frank J Suslavich, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 750 E 34th St, Hibbing, MN 55746 Phone: 218-262-4881 Fax: 218-362-6699 | |
Dr. Daniel Scott Vechell, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1200 E 25th St, Hibbing, MN 55746 Phone: 218-312-3005 Fax: 218-312-3003 | |
Dr. Gerald Thomas Mccullough, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 750 E 34th St, Hibbing, MN 55746 Phone: 218-262-4881 Fax: 218-362-6699 | |
Anne T Goldschmidt, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 750 E 34th St, Hibbing, MN 55746 Phone: 218-262-4881 Fax: 218-362-6699 | |
William Schwartau, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 750 E 34th St, Hibbing, MN 55746 Phone: 218-362-6683 Fax: 218-362-6684 | |
Dr. Christopher Mark Reilly, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 750 E 34th St, Hibbing, MN 55746 Phone: 218-262-4881 Fax: 218-362-6699 |